Literature DB >> 10609958

Expression of a nonclassical MHC class Ib molecule in the eye.

J Y Niederkorn1, E Y Chiang, T Ungchusri, I Stroynowski.   

Abstract

BACKGROUND: MHC class Ia molecules are absent, or expressed at low levels, on cells lining the anterior chamber of the eye, an immune-privileged site. Although the scarcity of class Ia MHC antigens may protect cells from T cell-mediated tissue injury, it may also render them vulnerable to natural killer cell-mediated cytolysis. There is growing evidence that MHC class Ib molecules share similar functions to class Ia. In this study, we examine the expression and distribution of Qa-2, one of the best-characterized murine MHC class Ib molecules in the eye.
METHODS: The transcription of Qa-2 mRNA in whole eye and eye-derived cells was analyzed by sensitive and specific RNase protection and reverse transcription-polymerase chain reaction assays. Immunohistochemistry, flow cytometry, and ELISA were used to determine whether Qa-2 was expressed as cell surface proteins. Expression levels of Qa-2 were monitored in resting cells and cells stimulated with interferon-gamma.
RESULTS: Expression of membrane-bound and soluble Qa-2 isoforms was detected in various tissues of the eye, including cell subsets lining the anterior chamber. Immunohistological staining revealed Qa-2 expression on corneal epithelium as well as endothelium, iris ciliary bodies, and retina. These observations were confirmed by analysis of cultured, eye-derived cells. Qa-2 expression was inducible by interferon-gamma. Qa-2 was not detected in lens cells.
CONCLUSIONS: The results demonstrate that membrane-bound and soluble MHC class Ib molecules are expressed by eye cells. Expression of Qa-2 in the corneal endothelium and other substructures lining the anterior chamber suggests that this class Ib protein may contribute to the immune-privileged status of the anterior chamber.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609958     DOI: 10.1097/00007890-199912150-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

Review 1.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Immune escape mechanisms of intraocular tumors.

Authors:  Jerry Y Niederkorn
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

3.  Vitamins inhibit oxidant-induced apoptosis of corneal endothelial cells.

Authors:  Nermin Serbecic; Sven Christoph Beutelspacher
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

Review 4.  Corneal lymphangiogenesis in herpetic stromal keratitis.

Authors:  Paul J Park; Michael Chang; Nitin Garg; Jimmy Zhu; Jin-Hong Chang; Deepak Shukla
Journal:  Surv Ophthalmol       Date:  2014-06-10       Impact factor: 6.048

5.  Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  Cancer Res       Date:  2011-02-09       Impact factor: 12.701

6.  Role of the Fas pathway in Pseudomonas aeruginosa keratitis.

Authors:  Zimei Zhou; Minhao Wu; Ronald P Barrett; Sharon A McClellan; Yunfan Zhang; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

7.  The role of tapasin in MHC class I protein trafficking in embryos and T cells.

Authors:  Paula W Lampton; Carmit Y Goldstein; Carol M Warner
Journal:  J Reprod Immunol       Date:  2007-12-03       Impact factor: 4.054

8.  Role of NKT cells in anterior chamber-associated immune deviation.

Authors:  Jerry Y Niederkorn
Journal:  Expert Rev Clin Immunol       Date:  2009-03       Impact factor: 4.473

9.  Arginine depletion as a mechanism for the immune privilege of corneal allografts.

Authors:  Hongmei Fu; Adnan Khan; David Coe; Sarah Zaher; Jian-Guo Chai; Pascale Kropf; Ingrid Müller; Daniel F P Larkin; Andrew J T George
Journal:  Eur J Immunol       Date:  2011-09-06       Impact factor: 5.532

10.  Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?

Authors:  Jerry Y Niederkorn
Journal:  Front Immunol       Date:  2012-06-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.